Author: Reuters Econ

Find latest business news from every corner of the globe at Reuters.com, your online source for breaking international news coverage.

Some of the biggest global drugmakers, undeterred by mounting Sino-U.S. tensions, are scouring for deals in China to replenish drug pipelines and boost their presence in the world’s second-biggest pharmaceutical market, industry executives and investment bankers said.

China’s central bank’s decision to lower the collateral requirement for medium-term loans will alleviate the “asset famine” pressure on the bond market, state media reported on Tuesday, citing a source.